Stock Events

Stock Events

Denali Therapeutics (DNLI) Q3 2024 Earnings

1AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.86

-0.77

-0.68

-0.59

Details

Expected EPS

-0.702465

Actual EPS

-0.59

Surprise EPS

0.11

Surprise Percent

+16.01%

Description

Denali Therapeutics (DNLI) has reported earnings of -0.59 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.